| R × S1 |
Does malignant mesothelioma have a high symptomatic burden when compared to other malignant diagnoses? |
| R × S2 |
Do people living with malignant mesothelioma need symptom palliation from the time of diagnosis? |
| R × S3 |
What are the different characteristics of pain frequently encountered in malignant mesothelioma? |
| R × S4 |
What are the key modalities for treating pain in malignant mesothelioma? |
| R × S5 |
Do early interventional pain techniques offer advantages over systemic therapies for malignant mesothelioma patients? |
| R × S6 |
What are the interventions to manage dyspnoea in malignant mesothelioma? |
| R × S7-R × S10 |
See Chapter 4 |
| R × S11 |
Does chemotherapy for malignant mesothelioma improve quality of life or functional status independent of its effect on tumour response? |
| R × S12 |
What are the psychosocial needs of patients with malignant mesothelioma? |
| R × S13 |
What are the psychosocial needs of carers and families of people diagnosed with malignant mesothelioma? |
| R × S14 |
For Q12 and 13, do these needs change in relation to proximity to death? |
| R × S15 |
Are there effective psychosocial interventions to assist people diagnosed with malignant mesothelioma and/or their carers and families to cope with their illness? See also RxS5. |
| R × S16 |
What are the legal compensation issues for patients and/or families with malignant mesothelioma? |
| R × S17 |
Do people diagnosed with malignant mesothelioma use complementary therapies to treat or manage their illness? |
| R × S18 |
Do people with malignant mesothelioma use alternate therapies to treat or manage their illness? |
| R × S19 |
Do health care providers support the use of complementary and/or alternate therapies by people diagnosed with malignant mesothelioma? |
| R × 20 |
Does nutritional assessment and support improve survival and/or quality of life in patients with mesothelioma? |
| R × 21 |
Do exercise programs improve survival and/or quality of life in patients with mesothelioma? |
